# FDA Reviews PMTA Regulatory Framework

The U.S. Food and Drug Administration (FDA) is undertaking a review of its Premarket Tobacco Product Application (PMTA) regulatory framework to consider potential changes, including new rulemaking, aimed at better addressing current market conditions and enhancing public health protections. While this evaluation is ongoing, the FDA will continue to process PMTA submissions and make regulatory decisions under the existing statutory requirements. Any future modifications to the framework will be developed with public input and in accordance with applicable law.

- Procurement professionals should note that ongoing PMTA submissions remain subject to current regulations, ensuring continuity in application processing.
- Potential regulatory changes could impact future submission requirements and compliance obligations for contractors and vendors involved in tobacco product development and regulatory consulting.
- Organizations engaged in regulatory affairs and compliance services may find opportunities to support stakeholders adapting to forthcoming rule changes.
- Stakeholders are encouraged to engage in public comment opportunities to influence the evolving regulatory landscape affecting tobacco product approvals.

**Jurisdictions:** federal
**Industries:** Healthcare
**Topics:** Regulatory Compliance
**Published:** September 29, 2026

### Government Entities
- U.S. Food and Drug Administration (FDA)
- U.S. Department of Health and Human Services (HHS)

### Sources
- [FDA intends to evaluate changes to the PMTA regulatory framework | FDA](https://www.fda.gov/news-events/press-announcements/fda-intends-evaluate-changes-pmta-regulatory-framework) - FDA